Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2018

Open Access 01-12-2018 | Research

Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species

Authors: Eric D. Laing, Moushimi Amaya, Chanakha K. Navaratnarajah, Yan-Ru Feng, Roberto Cattaneo, Lin-Fa Wang, Christopher C. Broder

Published in: Virology Journal | Issue 1/2018

Login to get access

Abstract

Background

Hendra virus and Nipah virus are zoonotic viruses that have caused severe to fatal disease in livestock and human populations. The isolation of Cedar virus, a non-pathogenic virus species in the genus Henipavirus, closely-related to the highly pathogenic Hendra virus and Nipah virus offers an opportunity to investigate differences in pathogenesis and receptor tropism among these viruses.

Methods

We constructed full-length cDNA clones of Cedar virus from synthetic oligonucleotides and rescued two replication-competent, recombinant Cedar virus variants: a recombinant wild-type Cedar virus and a recombinant Cedar virus that expresses a green fluorescent protein from an open reading frame inserted between the phosphoprotein and matrix genes. Replication kinetics of both viruses and stimulation of the interferon pathway were characterized in vitro. Cellular tropism for ephrin-B type ligands was qualitatively investigated by microscopy and quantitatively by a split-luciferase fusion assay.

Results

Successful rescue of recombinant Cedar virus expressing a green fluorescent protein did not significantly affect virus replication compared to the recombinant wild-type Cedar virus. We demonstrated that recombinant Cedar virus stimulated the interferon pathway and utilized the established Hendra virus and Nipah virus receptor, ephrin-B2, but not ephrin-B3 to mediate virus entry. We further characterized virus-mediated membrane fusion kinetics of Cedar virus with the known henipavirus receptors ephrin-B2 and ephrin-B3.

Conclusions

The recombinant Cedar virus platform may be utilized to characterize the determinants of pathogenesis across the henipaviruses, investigate their receptor tropisms, and identify novel pan-henipavirus antivirals. Moreover, these experiments can be conducted safely under BSL-2 conditions.
Literature
1.
Wang LF, Yu M, Hansson E, Pritchard LI, Shiell B, Michalski WP, et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol. 2000;74:9972–9.CrossRefPubMedPubMedCentral
2.
Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol. 2017;22:97–104.CrossRefPubMed
3.
Luby SP, Broder CC. Paramyxoviruses: Henipaviruses. In: Le Duc JWKRSL, editor. Viral Infections of Humans, Epidemiology and Control. New York: Springer Science+Business Media; 2014. p. 519–36.
4.
Wang LF, Mackenzie JS, Broder CC. Henipaviruses. In: Knipe DMHPM, editor. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1070–85.
5.
Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust. 1995;162:642–5.PubMed
6.
Centers for Disease Control and Prevention (CDC). Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48:265–9.
7.
Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet. 1999;354:1253–6.CrossRefPubMed
8.
Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354:1257–9.CrossRefPubMed
9.
Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288:1432–5.CrossRefPubMed
10.
11.
Tan CT, Wong KT. Nipah encephalitis outbreak in Malaysia. Ann Acad Med Singapore. 2003;32:112–7.PubMed
12.
Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. 2004;10:2082–7.CrossRefPubMedPubMedCentral
13.
Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis. 2005;11:1594–7.CrossRefPubMedPubMedCentral
14.
Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006;12:235–40.CrossRefPubMedPubMedCentral
15.
Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol. 2006;4:23–35.CrossRefPubMed
16.
Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A. 2005;102:10652–7.CrossRefPubMedPubMedCentral
17.
Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436:401–5.CrossRefPubMed
18.
Xu K, Broder CC, Nikolov DB. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors. Semin Cell Dev Biol. 2012;23:116–23.CrossRefPubMed
19.
Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Mühlberger E, et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for nipah virus. PLoS Pathog. 2006;2:e7.CrossRefPubMedPubMedCentral
20.
Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol. 2007;81:5893–901.CrossRefPubMedPubMedCentral
21.
Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol. 2001;230:151–60.CrossRefPubMed
22.
23.
Hooper P, Zaki S, Daniels P, Middleton D. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect. 2001;3:315–22.CrossRefPubMed
24.
Wong KT, Shieh W-J, Kumar S, Norain K, Abdullah W, Guarner J, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161:2153–67.CrossRefPubMedPubMedCentral
25.
Maisner A, Neufeld J, Weingartl H. Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro. Thromb Haemost. 2009;102:1014–23.CrossRefPubMed
26.
27.
Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, Westbury HA, et al. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J. 1998;76:813–8.CrossRefPubMed
28.
29.
Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF. Experimental hendra virus infectionin pregnant guinea-pigs and fruit Bats (Pteropus poliocephalus). J Comp Pathol. 2000;122:201–7.CrossRefPubMed
30.
Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol. 2002;126:124–36.CrossRefPubMed
31.
Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, et al. A golden hamster model for human acute Nipah virus infection. Am J Pathol. 2003;163:2127–37.CrossRefPubMedPubMedCentral
32.
Negrete OA, Chu D, Aguilar HC, Lee B. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. J Virol. 2007;81:10804–14.CrossRefPubMedPubMedCentral
33.
Halpin K, Young PL, Field H, Mackenzie JS. Newly discovered viruses of flying foxes. Vet Microbiol. 1999;68:83–7.CrossRefPubMed
34.
Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol. 2000;81(Pt 8):1927–32.CrossRefPubMed
35.
Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, Chua BH, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 2002;4:145–51.CrossRefPubMed
36.
Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 2011;85:946–51.CrossRefPubMedPubMedCentral
37.
Epstein JH, Field HE, Luby S, Pulliam JR, Daszak P. Nipah virus: impact, origins, and causes of emergence. Curr Infect Dis Rep. 2006;8:59–65.CrossRefPubMed
38.
Plowright RK, Eby P, Hudson PJ, Smith IL, Westcott D, Bryden WL, et al. Ecological dynamics of emerging bat virus spillover. Proc Biol Sci. 2015;282:20142124.CrossRefPubMedPubMedCentral
39.
Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, Clemins T, et al. Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis. 2002;8:987–8.CrossRefPubMedPubMedCentral
40.
Wacharapluesadee S, Boongird K, Wanghongsa S, Ratanasetyuth N, Supavonwong P, Saengsen D, et al. A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand: evidence for seasonal preference in disease transmission. Vector-Borne and Zoonotic Diseases. 2010;10:183–90.CrossRefPubMed
41.
Sendow I, Ratnawati A, Taylor T, Adjid RMA, Saepulloh M, Barr J, et al. Nipah virus in the fruit bat Pteropus vampyrus in Sumatera, Indonesia. PLoS One. 2013;8:e69544.CrossRefPubMedPubMedCentral
42.
Iehle C, Razafitrimo G, Razainirina J, Andriaholinirina N, Goodman SM, Faure C, et al. Henipavirus and Tioman virus antibodies in pteropodid bats. Madagascar. Emerg Infect Dis. 2007;13:159–61.CrossRefPubMed
43.
Hayman DT, Suu-Ire R, Breed AC, McEachern JA, Wang L, Wood JL, et al. Evidence of henipavirus infection in West African fruit bats. PLoS One. 2008;3:e2739.CrossRefPubMedPubMedCentral
44.
Peel AJ, Baker KS, Crameri G, Barr JA, Hayman DT, Wright E, et al. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One. 2012;7:e30346.CrossRefPubMedPubMedCentral
45.
Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun. 2014;5:5342.CrossRefPubMedPubMedCentral
46.
47.
48.
Wu Z, Yang L, Yang F, Ren X, Jiang J, Dong J, et al. Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012. Emerg Infect Dis. 2014;20:1064–6.PubMedPubMedCentral
49.
Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, Middleton D, et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 2012;8:e1002836.CrossRefPubMedPubMedCentral
50.
Lieu KG, Marsh GA, Wang L-F, Netter HJ. The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2. Antiviral Res. 2015;124:69–76.CrossRefPubMed
51.
Shaw ML, Garcia-Sastre A, Palese P, Basler CF. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol. 2004;78:5633–41.CrossRefPubMedPubMedCentral
52.
Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol. 2005;79:6078–88.CrossRefPubMedPubMedCentral
53.
Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J Virol. 2009;83:7828–41.CrossRefPubMedPubMedCentral
54.
Rodriguez JJ, Wang LF, Horvath CM. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol. 2003;77:11842–5.CrossRefPubMedPubMedCentral
55.
56.
Rodriguez JJ, Horvath CM. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol. 2004;17:210–9.CrossRefPubMed
57.
Satterfield BA, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, et al. The immunomodulating V and W proteins of Nipah virus determine disease course. Nat Commun. 2015;6:7483.CrossRefPubMedPubMedCentral
58.
Palese P, Zheng H, Engelhardt OG, Pleschka S, García-Sastre A. Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci U S A. 1996;93:11354–8.CrossRefPubMedPubMedCentral
59.
Pfaller CK, Cattaneo R, Schnell MJ. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology. 2015;479-480:331–44.CrossRefPubMed
60.
Yoneda M, Guillaume V, Ikeda F, Sakuma Y, Sato H, Wild TF, et al. Establishment of a Nipah virus rescue system. Proc Natl Acad Sci U S A. 2006;103:16508–13.CrossRefPubMedPubMedCentral
61.
Freiberg A, Dolores LK, Enterlein S, Flick R. Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA. Virology. 2008;370:33–44.CrossRefPubMed
62.
Yoneda M, Guillaume V, Sato H, Fujita K, Georges-Courbot M-C, Ikeda F, et al. The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One. 2010;5:e12709.CrossRefPubMedPubMedCentral
63.
Marsh GA, Virtue ER, Smith I, Todd S, Arkinstall R, Frazer L, et al. Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virol J. 2013;10:95.CrossRefPubMedPubMedCentral
64.
Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, et al. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. J Virol. 2015;89:1242–53.CrossRefPubMed
65.
Peeters BP, de Leeuw OS, Koch G, Gielkens AL. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 1999;73:5001–9.PubMedPubMedCentral
66.
Shagin DA, Barsova EV, Yanushevich YG, Fradkov AF, Lukyanov KA, Labas YA, et al. GFP-like proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol Biol Evol. 2004;21:841–50.CrossRefPubMed
67.
Chan YP, Yan L, Feng YR, Broder CC. Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery. Methods Mol Biol. 2009;525:31–58. xiiiCrossRefPubMedPubMedCentral
68.
Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet J-C, Roth JA, et al. Recombinant nipah virus vaccines protect pigs against challenge. J Virol. 2006;80:7929–38.CrossRefPubMedPubMedCentral
69.
Navaratnarajah CK, Rosemarie Q, Cattaneo R. A structurally unresolved head segment of defined length favors proper measles virus hemagglutinin tetramerization and efficient membrane fusion triggering. J Virol. 2015;90:68–75.CrossRefPubMedPubMedCentral
70.
Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol. 2006;80:891–9.CrossRefPubMedPubMedCentral
71.
Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, et al. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology. 2008;372:357–71.CrossRefPubMed
72.
Park M-S, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, et al. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol. 2003;77:1501–11.CrossRefPubMedPubMedCentral
73.
74.
75.
76.
Krüger N, Hoffmann M, Weis M, Drexler JF, Müller MA, Winter C, et al. Surface glycoproteins of an African Henipavirus induce syncytium formation in a cell line derived from an African fruit bat, Hypsignathus monstrosus. J Virol. 2013;87:13889–91.CrossRefPubMedPubMedCentral
77.
Weis M, Behner L, Hoffmann M, Krüger N, Herrler G, Drosten C, et al. Characterization of African bat henipavirus GH-M74a glycoproteins. J Gen Virol. 2014;95(Pt 3):539–48.CrossRefPubMed
78.
Lee B, Pernet O, Ahmed AA, Zeltina A, Beaty SM, Bowden TA. Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus. Proc Natl Acad Sci U S A. 2015;112:E2156–65.CrossRefPubMedPubMedCentral
79.
Rissanen I, Ahmed AA, Azarm K, Beaty S, Hong P, Nambulli S, et al. Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses. Nat Commun. 2017;8:16060.CrossRefPubMedPubMedCentral
80.
Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013;100:8–13.CrossRefPubMedPubMedCentral
81.
82.
Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang L-F, Middleton D, et al. Immunization strategies against henipaviruses. Curr Top Microbiol Immunol. 2012;359:197–223.PubMedPubMedCentral
83.
Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg Infect Dis. 2014;20:372–9.CrossRefPubMedPubMedCentral
84.
Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, et al. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 2011;29:5623–30.CrossRefPubMedPubMedCentral
85.
Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, et al. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med. 2012;4:146ra107.CrossRefPubMedPubMedCentral
86.
Mire CE, Geisbert JB, Agans KN, Feng Y-R, Fenton KA, Bossart KN, et al. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. J Virol. 2014;88:4624–31.CrossRefPubMedPubMedCentral
87.
Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis. 2008;197:846–53.CrossRefPubMed
88.
Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog. 2009;5:e1000642.CrossRefPubMedPubMedCentral
89.
Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, et al. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Sci Transl Med. 2011;3:105ra103.CrossRefPubMedPubMedCentral
90.
Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, et al. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med. 2014;6:242ra82.CrossRefPubMedPubMedCentral
91.
Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog. 2013;9:e1003684.CrossRefPubMedPubMedCentral
92.
Peel AJ, Sargan DR, Baker KS, Hayman DT, Barr JA, Crameri G, et al. Continent-wide panmixia of an African fruit bat facilitates transmission of potentially zoonotic viruses. Nat Commun. 2013;4:2770.CrossRefPubMed
Metadata
Title
Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species
Authors
Eric D. Laing
Moushimi Amaya
Chanakha K. Navaratnarajah
Yan-Ru Feng
Roberto Cattaneo
Lin-Fa Wang
Christopher C. Broder
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2018
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-018-0964-0

Other articles of this Issue 1/2018

Virology Journal 1/2018 Go to the issue

Research

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix

Research

Protection induced by a gp90 protein-based vaccine derived from a Reticuloendotheliosis virus strain isolated from a contaminated IBD vaccine

Research

Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis

Research

Evidence that Lokern virus (family Peribunyaviridae) is a reassortant that acquired its small and large genome segments from Main Drain virus and its medium genome segment from an undiscovered virus

Research

Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study

Short report

Characterization of a PCV2d-2 isolate by experimental infection of pigs

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits